期刊文献+

脐血和外周血来源的巨核细胞体外扩增差异的研究 被引量:3

Difference in ex vivo expansion of megakaryocytes derived from umbilical cord blood and peripheral blood
原文传递
导出
摘要 目的建立外周血(peripheral blood,PB)和脐血(cord blood,CB)来源的CD3+4细胞体外定向诱导扩增巨核细胞(megakaryocyte,MK)的最佳体系,探讨两种来源巨核细胞的扩增差异。方法以Ficoll-Hapaque分离“动员”的外周血和脐血单个核细胞,免疫磁珠分离纯化CD3+4细胞,在含胎牛血清的液体培养体系中,以不同细胞因子组合诱导两种来源的CD3+4细胞,定时进行细胞计数和流式细胞术检测培养体系中CD4+1细胞的含量;同时采用甲基纤维素半固体培养法进行巨核细胞集落培养,测定巨核细胞集落形成单位的数量。结果在血小板生成素(thrombopoietin,TPO)+胎肝酪氨酸激酶配体(FLT-3ligand,FL)+白介素6(interleukin-6,IL-6)+IL-3组合中,外周血来源的CD4+1细胞第10天扩增了131±18倍,脐血来源的CD4+1细胞在培养的第14天扩增了193±25倍,为增殖高峰。均明显高于同来源的其他3组(P<0.05),随着时间的推移两者的CD4+1细胞扩增倍数均呈下降趋势。结论TPO+FL+IL-6+IL-3组合均为CB和PB体外诱导扩增巨核细胞的最佳组合。CB来源的巨核细胞较PB来源的巨核细胞有更强的增生能力,而PB来源的CD3+4细胞产生巨核细胞的时间较CB来源的短,与临床上外周血造血干细胞移植的血小板造血重建快于脐血移植相一致。 Objective Currently, thrombocytopenia is typically observed in patients undergoing hematopioetic stem cell transplantation (HSCT), high-dose chemotherapy or irradiation. Severe thrombocytopenia can cause intestinal and intracranial hemorrhage. To transfuse ex vivo-expanded megakaryocytes (MK) into patients can reinforce the ability of platelet formation and shorten the time of platelet recovery. Therefore it is one of the effective approaches to reduce the danger. The purpose of the present study was to explore the differences in MK expansion between CD34^+ stem cells derived from umbilical cord blood (CB) and peripheral blood (PB) and to establish the most optimal culture system. Methods Mononuclear cells were isolated by density gradient centrifugation over Ficoll-Hypaque gradient solution. CD34^+ cells were isolated by positive selection using an immunomagnetic separation system and the selected CD34^+ cells were seeded in Iscove's modified Dulbecco's medium (IMDM) supplemented with fetal calf serum (FCS) and certain kinds of cytokines. After 15 - 17 days of culture, the cells were counted and the content of CD41^+ cells was determined by using flow cytometry, and the number of megakaryocyte colonyforming unit (CFU-MK) was simultaneously measured. Results After the defined days of culture, the cytokine combination of thrombopoietin (TPO) + fetal liver tyrosine kinase ligand (FL) + IL-6 + IL-3 showed to be the most suitable for beth PB and CB to obtain high numbers of MK, and to be better than any of the other three groups(P 〈0. 05). The CD41^+ cells from CB were expanded by193± 25 fold on day 14, and those from PB were expanded by 131 ± 18 fold on day 10. The number of CD1^+ cells from beth CB and PB decreased. Conclusion For PB and CB, the cytokine combination of TPO + FL + IL-6 + IL-3 is most suitable for obtaining large number of MK and is the best combination for ex vivo MK expansion. MKs from CB seemed to have higher proliferation potential than that from PB, and the optimal culture duration of MK from PB is shorter than that of MK from CB.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2006年第11期869-872,共4页 Chinese Journal of Pediatrics
基金 广东省卫生厅科研基金资助项目(A2003195)
关键词 巨核细胞 细胞 培养 血液 胎血 细胞因子类 Megakaryocytes Cells,cultured Blood Fetal blood Cytokihes
  • 相关文献

参考文献8

  • 1Decaudin D,Vantelon JM,Bourhis JH,et al.Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.Bone Marrow Transplantation,2004,34:1089-1093.
  • 2Wendling F,Han ZC.Positive snd negative regulation of megakaryocytopoiesis.Bailliere's Clin Haematol,1997,10:29-45.
  • 3Majka M,Ratajczak J,Villaire G,et al.Thrombopoietin,but not cytokines binding to gp130 protein-coupled receptors,activates MAPKp42/44,AKT,and STAT proteins in normal human CD34+ cells,megakaryocytes,and platelets.Exp Hematol,2002,30:751-760.
  • 4Kratz-Albers K,Scheding S,Mohle R,et al.Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34+cells with stem cell factor and promegapoietin.Exp Hematol,2000,28:335-346.
  • 5van den Oudenrijn S,de Haas M,Calafat J,et al.A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes.Br J Haematol,1999,106:553-563.
  • 6Schipper LF,Brand A,Reniers N,et al.Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood.Exp Hematol,2003,31:324-330.
  • 7Steidl U,Kronenwett R,Rohr UP,et al.Gene expression profiling identifies significant difference between the moleclar phenotypes of bone marrow-derived and circulating human CD34+hematopoietic stem cells.Blood,2002,99:2037-2044.
  • 8Mattia G,Vulcano F,Milazzo L,et al.Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.Blood,2002,99:888-897.

同被引文献43

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部